Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sprint Bioscience AB | 17,757,018 | net | 24 Apr 2025 | tx 3+17,757,018 |
| bayn europe | 825,300 | net | 29 Apr 2022 | tx 4+825,300 |
| First Venture Sweden AB | 312,500 | net | 29 Apr 2022 | tx 1+312,500 |
| Kiliaro AB | 66,387 | net | 20 Sept 2021 | tx 2+66,387 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Apr 2025 | PURCHASE | Sprint Bioscience AB | 6,432,591 | 0.66 SEK | first after silence |
| 15 Nov 2022 | PURCHASE | Sprint Bioscience AB | 4,891,836 | 0.75 SEK | |
| 29 Apr 2022 | PURCHASE | First Venture Sweden AB | 312,500 | 16.00 SEK | |
| 29 Apr 2022 | PURCHASE | bayn europe | 312,500 | 16.00 SEK | |
| 28 Sept 2021 | PURCHASE | bayn europe | 160,300 | 23.46 SEK | |
| 24 Sept 2021 | PURCHASE | bayn europe | 40,000 | 23.40 SEK | anomaly |
| 20 Sept 2021 | PURCHASE | Kiliaro AB | 57,591 | 4.52 SEK | anomaly |
| 20 Sept 2021 | PURCHASE | Kiliaro AB | 8,796 | 0.55 SEK | derivanomaly |
1 purchase reported after at least 12 months of silence — most recent on 24 Apr 2025.